Paul Hopper

Paul Hopper

Vermögen: 1 Mio $ am 31.07.2026

70 Jahre
Health Technology
Commercial Services
Finance

Profil

Paul A. Hopper founded Prescient Therapeutics Ltd. in 1986, where he worked as Non-Executive Director from 2014 to 2020, Imugene Ltd. in 2012, where he is working as Executive Chairman from 2014, Radiopharm Theranostics Ltd. in 2021, where he is working as Executive Chairman from 2021, and various other companies.
Mr. Hopper also founded Pathway Oncology Pty Ltd., Glioblast Pty Ltd., Polynoma LLC, where he worked as Lead Director, and various other companies.
Mr. Hopper also currently works at Vaxinia Pty Ltd., as Chairman, Cappello Group, Inc., as Managing Director from 2015, Biolife Science Ltd., as Director, and various other companies.
Mr. Hopper also formerly worked at CAQ Holdings Ltd., as Executive Chairman in 2008, Viralytics Pty Ltd., as Executive Chairman from 2012 to 2013, Botanix Pharmaceuticals Ltd., as Executive Chairman in 2007, and various other companies.
Mr. Hopper received his undergraduate degree from The University of New South Wales.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
24.07.2025 12.614.263 ( 2,58 % ) 753 072 $ 31.07.2026
18.03.2026 54.150.000 ( 1,38 % ) 532 295 $ 31.07.2026

Aktive Positionen von Paul Hopper

UnternehmenPositionBeginn
IMUGENE LIMITED Gründer 31.10.2012
RADIOPHARM THERANOSTICS LIMITED Gründer 01.01.2021
Vorsitzender -
Direktor/Vorstandsmitglied -
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal 01.11.2005
Präsident -

Ehemalige bekannte Positionen von Paul Hopper

UnternehmenPositionEnde
CHIMERIC THERAPEUTICS LIMITED Gründer 25.11.2025
░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Paul Hopper im Detail an

Ausbildung von Paul Hopper

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

67

Beziehungen ersten Grades

33

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen33

Commercial Services

Finance

Finance

Health Technology

Finance

Retail Trade

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Commercial Services

Commercial Services

Finance

Health Technology

Commercial Services

Commercial Services

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

C19 Therapeutics Pty Ltd.

Bioscience Oncology Pty Ltd.

Health Services

Health Technology

  1. Börse
  2. Insiders
  3. Paul Hopper